- Report
- October 2025
- 99 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- October 2025
- 105 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- November 2024
- 108 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- March 2024
- 117 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- January 2024
- 110 Pages
Global
From €3500EUR$4,251USD£3,182GBP
The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more